Pricing
  1. US-listed companies
  2. GRI Bio, Inc.
  3. Raw

GRI Bio, Inc.【GRI】

Market cap
$229.07K
P/E ratio
SummaryFinancials
Back to summarized table
Dec 31,
2021		Dec 31,
2022		Dec 31,
2023		Dec 31,
2024
Net loss-9-7-13-8
Depreciation--00
Amortization of debt discounts and issuance costs--2-
Stock-based compensation expense1000
Fair Value Adjustment of Warrants--0-0-0
Change in operating lease right of use assets--0-
Change in operating lease right of use assets---0
Prepaid expenses and other current assets0-01-0
Accounts payable-0-02-0
Accrued expenses1-10-0
Operating lease liabilities---00
Cash used in operating activities-8-7-9-9
Purchase of property and equipment--0-
Cash used in investing activities-44-0-
Advances from employees--0-
Repayment of advances from employees--0-
Proceeds from Notes Payable--1-
Through Financing---9
At The Market Offering---4
Proceeds from issuance of common stock in financing transaction / under ATM facility--12-
Proceeds from warrant exercise--01
Payment for fractional shares in connection with reverse stock split---0
Cash acquired in reverse recapitalization--1-
Payment of reverse recapitalization costs--3-
Payment of deferred stock issuance costs--12
Payment of debt issuance costs--0-
Cash provided by financing activities1631112
Net increase in cash and cash equivalents4023
Stock Issued For Repayment Of Notes Payable--3-
Debt Discount And Additional Paid-In-Capital Recognized From Issuance Of Warrants--1-
Net Liabilities Assumed In Connection With Reverse Recapitalization--4-
Debt Issuance Costs and Financing Costs Incurred But Not Yet Paid--0-
Stock Issued For Payment Of Reverse Recapitalization Costs--2-
Warrants Issued--00